interferon

(redirected from Interferon beta-1b)
Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to Interferon beta-1b: Interferon beta-1a

in·ter·fer·on

 (ĭn′tər-fîr′ŏn′)
n.
1. Any of a group of glycoproteins that are produced by different cell types in response to various stimuli, such as exposure to a virus, bacterium, parasite, or other antigen, and that inhibit infection through mechanisms such as preventing viral replication or regulating the immune system.
2. Any of a group of synthetic glycoproteins that are structurally similar to these compounds and are used therapeutically, especially as antivirals.

interferon

(ˌɪntəˈfɪərɒn)
n
(Biochemistry) biochem any of a family of proteins made by cells in response to virus infection that prevent the growth of the virus. Some interferons can prevent cell growth and have been tested for use in cancer therapy
[C20: from interfere + -on]

in•ter•fer•on

(ˌɪn tərˈfɪər ɒn)

n.
any of various proteins, produced by virus-infected cells, that inhibit reproduction of the invading virus and induce resistance to further infection.
[1957; interfere + -on1]

in·ter·fer·on

(ĭn′tər-fîr′ŏn′)
Any of a group of proteins that are produced by animal cells in response to infection by a virus and that, in many cases, prevent replication of the virus. Some interferons trigger an immune response in the body. They have been investigated as treatment for many diseases, including certain cancers.

interferon

Immune system proteins that help to protect cells against attack by some kinds of viruses.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.interferon - an antiviral protein produced by cells that have been invaded by a virus; inhibits replication of the virus
alpha-interferon - a form of interferon that is produced endogenously and commercially for its pharmacological effects (including regulation of the immune system and antiviral and antineoplastic effects)
antiviral, antiviral agent, antiviral drug - any drug that destroys viruses
beta-interferon - a form of interferon that is produced by fibroblasts and have antiviral effects; used in the treatment of multiple sclerosis
gamma-interferon - a form of interferon that is produced by T cells and macrophages; involved in the activation of phagocytes
Translations

interferon

[ˌɪntəˈfɪərɒn] Ninterferón m

interferon

n (Chem) → Interferon nt

in·ter·fer·on

n. interferón, proteína natural liberada por células expuestas a la acción del virus que se usa en el tratamiento de infecciones y neoplasmas.

interferon

n interferón m; alpha (beta, etc.) interferon interferón alfa (beta, etc.); pegylated — interferón pegilado
References in periodicals archive ?
Contract award: pn 14/15 delivery of interferon beta-1b.
Prior Information Notice: Medicines containing interferon beta-1b.
Everyother-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).
Contract notice: Conclusion of discount agreements with the active substance Interferon beta-1b in accordance with 130a para.
This study evaluated the effectiveness of early interferon beta-1b (IFNB-1b) treatment in 465 people who had experienced a clinically isolating syndrome, or CIS, a single neurologic episode that indicates high risk for developing MS.
Food and Drug Administration (FDA)-approved first-line therapies for RMS are interferon beta preparations, including intramuscular (im) interferon beta-1a (Avonex, B iogen Idec, 2008), subcutaneous (SC) interferon beta-1a (Rebif, EMD Serono, 2009), SC interferon beta-1b (Betaseron, Bayer HealthCare Pharmaceuticals, 2010), and SC interferon beta-1b (Extavia, Novartis Pharmaceutical Company, 2012).
The researchers analyzed data from 465 MS patients from 18 European countries, as well as Israel and Canada who enrolled in 2002 and 2003 in a trial looking at the effectiveness of the drug interferon beta-1b in treating the disease.
Blood 25[OH]D levels were measured as part of a randomized trial originally designed to study patients given interferon beta-1b treatment.
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.
Severe necrotizing cutaneous lesions complicating treatment with interferon beta-1b.
Summary: TEHRAN (FNA)- A new study for comparing the efficacy of 250 micro/g or 500 micro/g interferon beta-1b with Glatiramer acetate for treating relapsing-remitting multiple sclerosis showed that both doses had similar clinical effects to Glatiramer acetate.

Full browser ?